Transplant candidates with severe left ventricular dysfunction managed with medical treatment: Characteristics and survival

Journal of the American College of Cardiology

Volumn 27, Issue 5, 1996, Pages 1192-1197

  Rickenbacher, Peter R ^a,b   Trindade, Pedro T ^a   Haywood, Guy A ^a   Vagelos, Randall H ^a   Schroeder, John S ^a   Willson, Kathy ^a   Prikazsky, Lisa ^a   Fowler, Michael B ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b Walter Margarethe Lichtenstein F   (Switzerland)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0029984648     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00587-0     Document Type: Article

References (23)

1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285: 1441-6.
2. Fuster V, Gersh B, Giuliani E, Tajik A, Brandenburg R, Frye R. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-31,
3. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
4. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-52.
5. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure (CONSENSUS). N Engl J Med 1987;316: 1429-35.
7. Pfeffer MA, Braunwald E, Moy LA, et al. Effect of captopril on mortality in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327: 669-77.
8. Stevenson LW, Fowler MB, Schroeder JS, Stevenson WG, Dracup KA, Fond V. Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Med 1987;83:871-6.
9. Goldberger JJ, Peter HB, Stroh JA, Cohen MN, Frishman WH. Prognostic factors in acute pulmonary edema. Arch Int Med 1986;146:489-93.
10. Kannel WB. Epidemiological aspects of heart failure. Cardiol Clin 1989;7: 1-9.
11. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
12. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study Subjects. Circulation 1993;88:107-15.
13. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
14. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-75.
15. Kaye MP. The Registry of the International Society for Heart and Lung Transplantation: Tenth Official Report - 1993. J Heart Lung Transplant 1993;12:541-8.
16. Cohn JN, Archibald DG, Francis GS, et al. Veterans Administration Cooperative Study on vasodilator therapy of heart failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation 1987;75 Suppl IV:IV-49-54.
17. Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989;14:564-70.
18. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992; 123:421-6.
19. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 84:778-86.
20. O'Connell JB, Bourge RC, Constanzo-Nordin MR, et al. Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for Health Professionals From the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992;86:1061-79.
21. Hunt SA. 24th Besthesda Conference: Cardiac Transplantation, J Am Coll Cardiol 1993;22:1-64.
22. Stevenson LW. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant 1991;10:468-76.
23. Stevenson LW, Warner SL, Steimle AE, et al. The impending crisis awaiting cardiac transplantation: modeling a solution based on selection. Circulation 1994;89:450-7.